{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T07:18:30Z","timestamp":1648970310862},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arzneimittelforschung"],"DOI":"10.1055\/s-0031-1299909","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T08:56:55Z","timestamp":1343725015000},"page":"423-429","source":"Crossref","is-referenced-by-count":0,"title":["From Toxic Precursors to Safe Drugs"],"prefix":"10.1055","volume":"52","author":[{"given":"Karl-Uwe","family":"Petersen","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pharmakologie und Toxikologie, Rheinisch-Westf\u00e4lische Technische Hochschule Aachen"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2011,12,26]]},"container-title":["Arzneimittelforschung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0031-1299909.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T23:42:14Z","timestamp":1495496534000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0031-1299909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,26]]},"references-count":0,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2002,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0031-1299909","relation":{},"ISSN":["0004-4172","1616-7066"],"issn-type":[{"value":"0004-4172","type":"print"},{"value":"1616-7066","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,26]]}}}